Cargando…
Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients
Background: Programmed cell death 1 ligand-1 (PD-L1) is an immune checkpoint molecule that acts to protect cancer cells from immune surveillance and is considered as a prognostic biomarker in several cancers, but the prognostic value of PD-L1 in bone and soft tissue sarcomas remains inconclusive. In...
Autores principales: | Wang, Feng, Yu, Tao, Ma, Chengbin, Yuan, Hongmou, Zhang, Haifei, Zhang, Zhiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280448/ https://www.ncbi.nlm.nih.gov/pubmed/32582532 http://dx.doi.org/10.3389/fonc.2020.00749 |
Ejemplares similares
-
The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta‐analysis
por: Wang, Feng, et al.
Publicado: (2019) -
Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
por: Zhu, Zhenhua, et al.
Publicado: (2017) -
T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas
por: Pollack, Seth M., et al.
Publicado: (2017) -
Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients
por: Jeong, Sohyun, et al.
Publicado: (2017) -
Status of programmed death-ligand 1 expression in sarcomas
por: Park, Hyung Kyu, et al.
Publicado: (2018)